Alzheimer’s Society comment:
‘The more we learn about dementia and how it relates to other conditions like diabetes, the more we’re able to explore whether existing drugs can double as dementia treatments. This study suggests that the drug metaformin may be one of the most promising candidates to do just that.
One in three people over the age of 65 will develop dementia. Given the huge cost and high profile failures of developing new treatments from scratch, looking at ways to use drugs like this to treat dementia is incredibly important.’
Research Officer Alzheimer’s Society
Research reference: Rachel Whitmer et al, ‘Anti-Hyperglycemic Therapy and Risk of Dementia: A New User Cohort Study’. Presented at Alzheimer’s Association International Conference, July 15 2013.
- One in three people over 65 will develop dementia
- Alzheimer’s Society research shows that 800,000 people in the UK have a form of dementia, more than half have Alzheimer’s disease. In less than ten years a million people will be living with dementia. This will soar to 1.7 million people by 2051
- Alzheimer’s Society champions the rights of people living with dementia and the millions of people who care for them
- Alzheimer’s Society works in England, Wales and Northern Ireland
- Alzheimer’s Society has a plan to deal with dementia. Help us support people to live well today and fight for a world without dementia tomorrow. We rely on voluntary donations to continue our vital work. You can donate now by calling 0845 306 0898 or visiting alzheimers.org.uk
- Alzheimer’s Society provides a National Dementia Helpline, the number is 0300 222 11 22 or visit alzheimers.org.uk
© Alzheimers Society - 15th July 2013